SYSTEM FOR FOCUSED TARGETING OF MAGNETO-AEROTACTIC-RESPONSIVE BACTERIA AND METHOD OF USE THEREOF

1 . A method of improving targeted delivery of at least one of a treatment agent, an imaging agent and a diagnostic agent attached to magneto-aerotactic-responsive bacteria adapted to self-locomote while subject to a magnetic field, the magneto-aerotactic-responsive bacteria depositing the at least one of a treatment agent, an imaging agent and a diagnostic agent at hypoxic zones in a patient, comprising:

adapting a total bolus escape time of a solution of the magneto-aerotactic responsive bacteria when injected into the patient in order to influence the targeting of a target zone with hypoxic zones in the patient, wherein decreasing the total bolus escape time favors a targeting, by the magneto-aerotactic-responsive bacteria, of one or more of the hypoxic zones at a farther distance from an injection site of the magneto-aerotactic-responsive bacteria while considering a decrease in velocity post-injection of said magneto-aerotactic-responsive bacteria when exposed to an environment of said patient.

2 . The method as defined in claim 1 , wherein the total bolus escape time is adapted by adjusting one or more of:

a concentration of the magneto-aerotactic-responsive bacteria in the solution;

a volume of the bolus;

a viscosity of the solution; and

a surface of the bolus exposed to a north of the magnetic field when the magneto-aerotactic-responsive bacteria are north-seeking, or a surface of the bolus exposed to a south of the magnetic field when the magneto-aerotactic-responsive bacteria are south-seeking.

3 . The method as defined in claim 1 , wherein the total bolus escape time is adapted by dividing, during injection, the bolus into smaller boluses injected into the patient in order to lower a bolus-volume as the individual volumes of each of the smaller boluses is less than the volume of the bolus.

4 . The method as defined in claim 1 , wherein increasing the total bolus escape time is achieved by heating the solution in the injection device prior to introduction into the patient.

5 . The method as defined in claim 1 , wherein increasing the total bolus escape time is achieved by reducing the rate of volume of injection into the patient.

6 . The method as defined in claim 1 , wherein the total bolus escape time is adapted by adjusting the shape of the bolus.

7 . The method as defined in claim 1 , wherein decreasing the total bolus escape time is in order to enable access to a portion of a tumor that is inaccessible by the injection device, necessitating the travel of the magneto-aerotactic-responsive bacteria from the injection point to the portion of the tumor.

8 . The method as defined in claim 1 , wherein the total bolus escape time is adapted by influencing a shape of the bolus through a selection of an appropriate injector.

9 . The method as defined in claim 1 , wherein the total bolus escape time is decreased by increasing the surface to volume ratio of the injected bolus.

10 . The method as defined in claim 1 , wherein an increase in total bolus escape time is favoured when targeting of hypoxic zones closer to the injection site is sought.

11 . A method of influencing a total bolus escape time of a solution of magneto-aerotactic-responsive bacteria attached to at least one of a treatment agent, an imaging agent and a diagnostic agent for injection into a patient, wherein the magneto-aerotactic-responsive bacteria is adapted to self-locomote while subject to a magnetic field, the magneto-aerotactic-responsive bacteria depositing the at least one of a treatment agent, an imaging agent and a diagnostic agent at a target zone with hypoxic zones in a patient, comprising:

at least one of increasing the surface-volume ratio of the bolus, decreasing the concentration of the magneto-aerotactic-responsive bacteria in the solution, decreasing the viscosity of the solution, and increasing the surface of the bolus exposed to the north of the magnetic field for north-seeking magneto-aerotactic-responsive bacteria and to the south of the magnetic field for south-seeking magneto-aerotactic-responsive bacteria, that is to decrease the total bolus escape time of the magneto-aerotactic-responsive bacteria; or

at least one of decreasing the surface-volume ratio of the bolus, increasing the concentration of the magneto-aerotactic-responsive bacteria in the solution, increasing the viscosity of the solution, and decreasing the surface of the bolus exposed to the north of the magnetic field for north-seeking magneto-aerotactic-responsive bacteria and to the south of the magnetic field for south-seeking magneto-aerotactic-responsive bacteria, that is to increase the total bolus escape time of the magneto-aerotactic-responsive bacteria,

whereby a lower total bolus escape time of the magneto-aerotactic responsive bacteria is for targeting one or more of the hypoxic zones of the target zone in said patient that are further from said injection site.

12 . The method as defined in claim 11 , whereby targeting of the one or more of the hypoxic zones in a tumor further from said injection site is considered when the injection device cannot access a region next to said hypoxic zones, requiring a greater travel of the magneto-aerotactic-responsive bacteria from the injection site to the hypoxic zones, the method comprising at least one of increasing the surface-volume ratio of the bolus, decreasing the concentration of the magneto-aerotactic-responsive bacteria in the bolus, decreasing the viscosity of the bolus, and increasing the surface of the bolus exposed to the north of the magnetic field for north-seeking magneto-aerotactic-responsive bacteria and to the south of the magnetic field for south-seeking magneto-aerotactic-responsive bacteria to decrease the total bolus escape time of the magneto-aerotactic-responsive bacteria.

13 . The method as defined in claim 11 , comprising at least one of increasing the surface-volume ratio of the bolus by dividing the bolus into smaller boluses.

14 . The method as defined in claim 11 , wherein the magneto-aerotactic responsive bacteria are attached to a treatment agent.

15 . The method as defined in claim 11 , wherein the bolus is prepared by further considering the velocity distribution of the magneto-aerotactic responsive bacteria in the bolus.